NO319058B1 - Gener for butyrobetain/krotonobetain-L-carnitinstoffskiftet og deres anvendelse for mikrobiologisk fremstilling av L-carnitin. - Google Patents
Gener for butyrobetain/krotonobetain-L-carnitinstoffskiftet og deres anvendelse for mikrobiologisk fremstilling av L-carnitin. Download PDFInfo
- Publication number
- NO319058B1 NO319058B1 NO19961385A NO961385A NO319058B1 NO 319058 B1 NO319058 B1 NO 319058B1 NO 19961385 A NO19961385 A NO 19961385A NO 961385 A NO961385 A NO 961385A NO 319058 B1 NO319058 B1 NO 319058B1
- Authority
- NO
- Norway
- Prior art keywords
- carnitine
- butyrobetaine
- genes
- plasmid
- crotonobetaine
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 97
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title claims abstract description 60
- 230000004060 metabolic process Effects 0.000 title claims abstract description 18
- GUYHPGUANSLONG-SNAWJCMRSA-N (E)-4-(trimethylammonio)but-2-enoate Chemical compound C[N+](C)(C)C\C=C\C([O-])=O GUYHPGUANSLONG-SNAWJCMRSA-N 0.000 title claims abstract description 15
- JHPNVNIEXXLNTR-UHFFFAOYSA-O 4-(trimethylammonio)butanoic acid Chemical compound C[N+](C)(C)CCCC(O)=O JHPNVNIEXXLNTR-UHFFFAOYSA-O 0.000 title claims abstract 10
- 230000002906 microbiologic effect Effects 0.000 title description 5
- 238000002360 preparation method Methods 0.000 title description 2
- 239000012634 fragment Substances 0.000 claims abstract description 47
- 239000013598 vector Substances 0.000 claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 claims abstract description 29
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 102000004190 Enzymes Human genes 0.000 claims abstract description 10
- 108090000790 Enzymes Proteins 0.000 claims abstract description 10
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 6
- 108010078791 Carrier Proteins Proteins 0.000 claims abstract description 5
- 102000014914 Carrier Proteins Human genes 0.000 claims abstract description 4
- 244000005700 microbiome Species 0.000 claims description 49
- 239000013612 plasmid Substances 0.000 claims description 39
- 241000589180 Rhizobium Species 0.000 claims description 24
- 241000589158 Agrobacterium Species 0.000 claims description 20
- 230000014509 gene expression Effects 0.000 claims description 10
- 238000013518 transcription Methods 0.000 claims description 8
- 230000035897 transcription Effects 0.000 claims description 8
- 241000589516 Pseudomonas Species 0.000 claims description 7
- 230000002068 genetic effect Effects 0.000 claims description 7
- 101710088194 Dehydrogenase Proteins 0.000 claims description 6
- 241000588722 Escherichia Species 0.000 claims description 5
- 102000003960 Ligases Human genes 0.000 claims description 5
- 108090000364 Ligases Proteins 0.000 claims description 5
- 238000010352 biotechnological method Methods 0.000 claims description 4
- 108090000604 Hydrolases Proteins 0.000 claims description 3
- 230000009471 action Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 241000589519 Comamonas Species 0.000 claims description 2
- 230000001771 impaired effect Effects 0.000 claims 1
- 238000011138 biotechnological process Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 36
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 23
- JHPNVNIEXXLNTR-UHFFFAOYSA-N 4-(trimethylammonio)butanoate Chemical compound C[N+](C)(C)CCCC([O-])=O JHPNVNIEXXLNTR-UHFFFAOYSA-N 0.000 description 19
- 238000000034 method Methods 0.000 description 15
- 101150079601 recA gene Proteins 0.000 description 13
- 238000009396 hybridization Methods 0.000 description 12
- 229960003237 betaine Drugs 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000010276 construction Methods 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 239000006916 nutrient agar Substances 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 238000005215 recombination Methods 0.000 description 6
- 238000010367 cloning Methods 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 241000589187 Rhizobium sp. Species 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 230000002759 chromosomal effect Effects 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000037353 metabolic pathway Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 241000701959 Escherichia virus Lambda Species 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 108010029922 carnitine dehydrogenase Proteins 0.000 description 3
- 239000013601 cosmid vector Substances 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 101150105245 HK4 gene Proteins 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 238000013452 biotechnological production Methods 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- PHIQHXFUZVPYII-LURJTMIESA-N (S)-carnitine Chemical compound C[N+](C)(C)C[C@@H](O)CC([O-])=O PHIQHXFUZVPYII-LURJTMIESA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010058892 Carnitine deficiency Diseases 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- 229930195714 L-glutamate Natural products 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 102000004879 Racemases and epimerases Human genes 0.000 description 1
- 108090001066 Racemases and epimerases Proteins 0.000 description 1
- 241000589194 Rhizobium leguminosarum Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 238000011166 aliquoting Methods 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012595 freezing medium Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000016505 systemic primary carnitine deficiency disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/007—Carnitine; Butyrobetaine; Crotonobetaine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/743—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Agrobacterium; Rhizobium; Bradyrhizobium
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH303693 | 1993-10-08 | ||
| CH3694 | 1994-01-06 | ||
| PCT/EP1994/003317 WO1995010613A1 (fr) | 1993-10-08 | 1994-10-07 | Genes permettant le metabolisme de la butyrobetaine/crotonobetaine-l-carnitine et leur utilisation pour la production microbiologique de l-carnitine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO961385D0 NO961385D0 (no) | 1996-04-03 |
| NO961385L NO961385L (no) | 1996-06-03 |
| NO319058B1 true NO319058B1 (no) | 2005-06-13 |
Family
ID=25683317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19961385A NO319058B1 (no) | 1993-10-08 | 1996-04-03 | Gener for butyrobetain/krotonobetain-L-carnitinstoffskiftet og deres anvendelse for mikrobiologisk fremstilling av L-carnitin. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5759824A (fr) |
| EP (1) | EP0722500B1 (fr) |
| JP (1) | JP3708543B2 (fr) |
| KR (1) | KR100346293B1 (fr) |
| CN (2) | CN1157480C (fr) |
| AT (1) | ATE257515T1 (fr) |
| AU (1) | AU7854694A (fr) |
| CA (1) | CA2173115C (fr) |
| CZ (1) | CZ288247B6 (fr) |
| DE (1) | DE59410350D1 (fr) |
| FI (1) | FI118568B (fr) |
| HU (1) | HU220798B1 (fr) |
| NO (1) | NO319058B1 (fr) |
| PL (1) | PL180300B1 (fr) |
| RU (1) | RU2133773C1 (fr) |
| SK (1) | SK280580B6 (fr) |
| WO (1) | WO1995010613A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19850426A1 (de) * | 1998-10-27 | 2000-05-04 | Sigma Tau Ind Farmaceuti | gamma-Butyrobetainyl-Coenzym A und Verfahren zu seiner Herstellung |
| SI1151130T1 (en) * | 1998-10-27 | 2005-06-30 | Sigma-Tau | Coenzyme useful for the synthesis of l-carnitine |
| DE19850433A1 (de) * | 1998-10-27 | 2000-05-25 | Sigma Tau Ind Farmaceuti | Crotonobetainyl-Coenzym A, Verfahren zu seiner Herstellung |
| US6337197B2 (en) | 1998-10-27 | 2002-01-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Coenzymes useful for the synthesis of L-carnitine |
| CN1469927A (zh) * | 2000-08-04 | 2004-01-21 | 通过增加底物转运增强工业生产 | |
| US6720168B2 (en) | 2000-08-04 | 2004-04-13 | Genencor International, Inc. | 2,5-DKG permeases |
| ES2282399T3 (es) * | 2001-01-31 | 2007-10-16 | Lonza Ag | Procedimiento microbiologico para la obtencion de l-carnitina. |
| US7229811B2 (en) | 2001-08-03 | 2007-06-12 | Genencor International, Inc. | 2,5-diketo-D-gluconic acid (2,5-DKG) permeases |
| ATE531803T1 (de) * | 2003-06-05 | 2011-11-15 | Ajinomoto Kk | Fermentierungsverfahren mittels veränderter bakterien mit einer erhöhten aufnahme von nebenprodukten |
| KR101166026B1 (ko) | 2004-07-12 | 2012-07-19 | 씨제이제일제당 (주) | 뉴로스포라 크라사 유래 ｌ-카르니틴 생합성 관련유전자를 포함하는 엔테로박테리아세 속 미생물 및 이를이용한 ｌ-카르니틴의 제조방법 |
| CN101212956A (zh) | 2005-07-05 | 2008-07-02 | 隆萨股份公司 | 生产干肉碱粉末或颗粒的喷雾干燥法 |
| ATE472600T1 (de) | 2005-07-19 | 2010-07-15 | Cj Cheiljedang Corp | Mikroorganismus der gattung enterobacteriacae mit genen in zusammenhang mit der biosynthese von l- carnitin sowie verfahren zur produktion von l- carnitin mit dem mikroorganismus |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59192095A (ja) * | 1983-04-13 | 1984-10-31 | Ajinomoto Co Inc | Ｌ−カルニチンの製造法 |
| IE902689A1 (en) * | 1989-07-28 | 1991-02-27 | Lonza Ag | A method of discontinuous production of l-carnitine by a¹microbiological process |
| IT1240833B (it) * | 1990-05-14 | 1993-12-17 | Sigma Tau Ind Farmaceuti | Procedimento biocatalitico per la produzione di l-(-)- carnitina da crotonilbetaina e ceppi di proteeae per l'uso in tale procedimento |
| RU2099418C1 (ru) * | 1991-11-21 | 1997-12-20 | Лонца Аг | Фрагмент днк, обеспечивающий использование бетаина, рекомбинантная плазмидная днк с фрагментом днк, обеспечивающим использование бетаина, штамм бактерий rhizobium/agrobacterium, предназначенный для стабильного хранения плазмиды с фрагментом днк, способ получения штамма бактерий |
-
1994
- 1994-10-07 US US08/615,191 patent/US5759824A/en not_active Expired - Lifetime
- 1994-10-07 AU AU78546/94A patent/AU7854694A/en not_active Abandoned
- 1994-10-07 CA CA002173115A patent/CA2173115C/fr not_active Expired - Fee Related
- 1994-10-07 CN CNB991207033A patent/CN1157480C/zh not_active Expired - Fee Related
- 1994-10-07 WO PCT/EP1994/003317 patent/WO1995010613A1/fr not_active Ceased
- 1994-10-07 AT AT94929520T patent/ATE257515T1/de active
- 1994-10-07 KR KR1019960701836A patent/KR100346293B1/ko not_active Expired - Fee Related
- 1994-10-07 CZ CZ19961005A patent/CZ288247B6/cs not_active IP Right Cessation
- 1994-10-07 HU HU9600904A patent/HU220798B1/hu not_active IP Right Cessation
- 1994-10-07 JP JP51125795A patent/JP3708543B2/ja not_active Expired - Fee Related
- 1994-10-07 EP EP94929520A patent/EP0722500B1/fr not_active Expired - Lifetime
- 1994-10-07 SK SK431-96A patent/SK280580B6/sk not_active IP Right Cessation
- 1994-10-07 DE DE59410350T patent/DE59410350D1/de not_active Expired - Lifetime
- 1994-10-07 PL PL94313968A patent/PL180300B1/pl unknown
- 1994-10-07 RU RU96108818A patent/RU2133773C1/ru not_active IP Right Cessation
- 1994-10-07 CN CN94193701A patent/CN1058523C/zh not_active Expired - Fee Related
-
1996
- 1996-04-03 NO NO19961385A patent/NO319058B1/no not_active IP Right Cessation
- 1996-04-04 FI FI961537A patent/FI118568B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI961537L (fi) | 1996-04-04 |
| HUT74825A (en) | 1997-02-28 |
| NO961385L (no) | 1996-06-03 |
| EP0722500A1 (fr) | 1996-07-24 |
| HU220798B1 (hu) | 2002-05-28 |
| EP0722500B1 (fr) | 2004-01-07 |
| CN1282791A (zh) | 2001-02-07 |
| KR100346293B1 (ko) | 2002-11-30 |
| ATE257515T1 (de) | 2004-01-15 |
| WO1995010613A1 (fr) | 1995-04-20 |
| AU7854694A (en) | 1995-05-04 |
| CA2173115A1 (fr) | 1995-04-20 |
| CN1157480C (zh) | 2004-07-14 |
| CZ288247B6 (en) | 2001-05-16 |
| DE59410350D1 (de) | 2004-02-12 |
| PL313968A1 (en) | 1996-08-05 |
| JP3708543B2 (ja) | 2005-10-19 |
| CA2173115C (fr) | 2005-07-26 |
| SK280580B6 (sk) | 2000-04-10 |
| FI118568B (fi) | 2007-12-31 |
| CZ100596A3 (en) | 1996-10-16 |
| NO961385D0 (no) | 1996-04-03 |
| JPH09503390A (ja) | 1997-04-08 |
| FI961537A0 (fi) | 1996-04-04 |
| RU2133773C1 (ru) | 1999-07-27 |
| US5759824A (en) | 1998-06-02 |
| CN1058523C (zh) | 2000-11-15 |
| SK43196A3 (en) | 1996-10-02 |
| CN1133066A (zh) | 1996-10-09 |
| PL180300B1 (pl) | 2001-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| De Bruijn et al. | Rhizobium meliloti 1021 has three differentially regulated loci involved in glutamine biosynthesis, none of which is essential for symbiotic nitrogen fixation | |
| US4278765A (en) | Method for preparing strains which produce aminoacids | |
| de Zamaroczy et al. | Functional organization of the glnB-glnA cluster of Azospirillum brasilense | |
| Walter et al. | Genetic characterization of the pdu operon: use of 1, 2-propanediol in Salmonella typhimurium | |
| Eberz et al. | Three trans-acting regulatory functions control hydrogenase synthesis in Alcaligenes eutrophus | |
| Liang et al. | Characterization of the ntrBC genes of Azospirillam brasilense Sp7: Their involvement in the regulation of nitrogenase synthesis and activity | |
| Thiel et al. | [13] Conjugal transfer of plasmids to cyanobacteria | |
| NO319058B1 (no) | Gener for butyrobetain/krotonobetain-L-carnitinstoffskiftet og deres anvendelse for mikrobiologisk fremstilling av L-carnitin. | |
| Gibson et al. | Analysis of the cbbXYZ operon in Rhodobacter sphaeroides | |
| HU201116B (en) | Process for producing plasmids having uncontrolled replication conduct under given circumstances | |
| JPH01174385A (ja) | Ｄｎａおよびその用途 | |
| Gomelsky et al. | The Rhodobacter sphaeroides 2.4. 1 rho gene: expression and genetic analysis of structure and function | |
| US20210324391A1 (en) | Recombinant microorganism, preparation method therefor and application thereof in producing coenzyme q10 | |
| CA2083407C (fr) | Microorganismes utilises comme agents de stabilisation des plasmides | |
| Lazzaroni et al. | Excretion of alkaline phosphatase by Escherichia coli K-12 pho constitutive mutants transformed with plasmids carrying the alkaline phosphatase structural gene | |
| Kormanec et al. | The Streptomyces aureofaciens homologue of the whiB gene is essential for sporulation; its expression correlates with the developmental stage | |
| Walker et al. | Construction of a transposon containing a gene for polygalacturonate trans-eliminase from Klebsiella oxytoca | |
| EP0240105B1 (fr) | Gène codant pour la biotine synthétase et son utilisation | |
| Turlin et al. | Complementation of Methylobacterium organophilum mutants affected in pyrroloquinoline quinone biosynthesis genes pqqE and pqqF by cloned Escherichia coli chromosomal DNA | |
| JP4085523B2 (ja) | 自然形質転換能を有する納豆菌 | |
| Fani et al. | Heterologous gene expression in an Escherichia coli population under starvation stress conditions | |
| Vosman et al. | Random insertional mutagenesis in Acinetobacter | |
| Pátek et al. | Expression of the threonine operon from Escherichia coli in Brevibacterium flavum and Corynebacterium glutamicum | |
| CN110964682A (zh) | L-赖氨酸耐受菌、生产菌及其用途 | |
| JPH11243976A (ja) | 単細胞又は多細胞生物、トレオニンアルドラーゼ遺伝子、該遺伝子を含有する構造体、該遺伝子を含有するベクター、形質転換生物、リボフラビンの製法及び生物、遺伝子もしくはベクターの使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |